| # | Drug | Count |
|---|---|---|
| 0 | FOLIC ACID | 10 |
| 1 | INFLIXIMAB | 8 |
| 2 | METHOTREXATE SODIUM | 8 |
| 3 | OMEPRAZOLE MAGNESIUM | 8 |
| 4 | ERGOCALCIFEROL | 7 |
| 5 | OLANZAPINE | 7 |
| 6 | OMEPRAZOLE | 7 |
| 7 | SIMVASTATIN | 7 |
| 8 | ADALIMUMAB | 6 |
| 9 | FELODIPINE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROQUINONE | 2 | 0.0034 |
| 1 | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | 2 | 0.0025 |
| 2 | FELODIPINE | 6 | 0.0005 |
| 3 | AMLODIPINE AND ATORVASTATIN | 2 | 0.0005 |
| 4 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 5 | RESMETIROM | 1 | 0.0004 |
| 6 | FLECAINIDE ACETATE | 2 | 0.0004 |
| 7 | AMIFAMPRIDINE PHOSPHATE | 1 | 0.0003 |
| 8 | EPTINEZUMAB-JJMR | 3 | 0.0003 |
| 9 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | HMG-CoA Reductase Inhibitor [EPC] | 11 |
| 1 | Proton Pump Inhibitor [EPC] | 11 |
| 2 | Vitamin B12 [EPC] | 11 |
| 3 | Vitamin C [EPC] | 11 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 5 | Vitamin D [EPC] | 10 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| 7 | Atypical Antipsychotic [EPC] | 7 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 7 |
| 9 | Factor Xa Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanin Synthesis Inhibitor [EPC] | 2 | 0.0018 |
| 1 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 2 | Calcitonin Gene-related Peptide Antagonist [EPC] | 3 | 0.0003 |
| 3 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 4 | TRPM8 Thermoreceptor Agonist [EPC] | 1 | 0.0002 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Glinide [EPC] | 1 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 8 | Progesterone [EPC] | 2 | 0.0001 |
| 9 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 2 | 0.0001 |